Peritoneal carcinomatosis;Peritonealkarzinose

Chirurg

Volumn 82, Issue 4, 2011, Pages 375-381

  Konigsrainer I ^a   Beckert, S ^a   Lehmann, T ^a   Ladurner, R ^a   Brucher B ^a   Konigsrainer A ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Hyperthermic intraperitoneal chemotherapy; Long term survival; Peritoneal carcinoma; Selection criteria; Surgical procedures

Indexed keywords

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER STAGING; FEMALE; FEMALE GENITAL TRACT TUMOR; GASTROINTESTINAL TUMOR; HUMAN; HYPERTHERMIC THERAPY; MALE; METASTASIS; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PERITONEUM; PERITONEUM TUMOR; PROGNOSIS; QUALITY OF LIFE; REGIONAL PERFUSION; SURVIVAL RATE; TUMOR VOLUME;

CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; FEMALE; GASTROINTESTINAL NEOPLASMS; GENITAL NEOPLASMS, FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PERITONEUM; PROGNOSIS; QUALITY OF LIFE; SURVIVAL RATE; TUMOR BURDEN;

EID: 79953328268     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-010-2049-5     Document Type: Article

References (18)

1. Al-Shammaa HA, Li Y, Yonemura Y (2008) Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. World J Gastroenterol 14: 1159-1166.
2. Esquivel J, Sticca R, Sugarbaker P et al (2007) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol 14(1): 128-133.
3. González-Moreno S, Ortega-Pérez G, González-Bayón L (2009) Indications and patient selection for cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Surg Oncol 100: 287-292.
4. Havrilesky LJ, Kulasingam SL, Matchar DB, Myers ER (2005) FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol 97: 183-191.
5. Huebner RH, Park KC, Shepherd JE et al (2000) A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41: 1177-1189.
6. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82: 359-374.
7. Pelz JO, Stojadinovic A, Nissan A et al (2009) Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis. J Surg Oncol 99(1): 9-15.
8. Pfannenberg C, Königsrainer I, Aschoff P et al (2009) (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 16(5): 1295-1303.
9. Roviello F, Caruso S, Marrelli D et al (2010) Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. Surg Oncol e1-e17.
10. Spratt JS, Adcock RA, Muskovin M et al (1980) Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 40: 256-260.
11. Stephens AD, Alderman R, Chang D et al (1999) Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6: 790-796.
12. Sugarbaker PH (1996) Observations concerning cancer spread within the peritoneal carcinomatosis: principles and management. Boston Kluwer Academic Publ, pp 79-100.
13. Trimble EL, Christian MC (2006) Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinoma. Gynecol Oncol 100: 3-4.
14. Verwaal VJ, Bruin S, Boot H et al (2008) 8-year-follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15: 2426-2432.
15. Yan TD, Welch I, Black D, Sugarbaker PH (2007) A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesotelioma. Ann Oncol 18: 827-834.
16. Yonemura Y, De Aretxabala X, Fujimura T et al (2001) Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology 48: 1776-1782.
17. Yonemura Y, Endou Y, Sasaki T et al (2010) Surgical treatment for peritoneal carcinomatosis from gastric cancer. EJSO 36: 1131-1138.
18. Zieker D, Königsrainer I, Tritschler I et al (2010) Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer. Int J Cancer 126(6): 1513-1520.